Söndag 9 November | 09:26:41 Europe / Stockholm

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-10-27 14:29:00

Redeye argues that the negative YTD share price performance does not reflect Xvivo’s underlying fundamental developments. We see a doubling potential in the share for this emerging niche leader in the coming 12 months, driven by strengthening sentiment and several near-term catalysts.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/